BPC-157

Research ChemicalExtensive Research

Also known as: Body Protection Compound-157 · Pentadecapeptide · PL 14736

A 15-amino-acid peptide derived from human gastric juice that demonstrates remarkable healing properties across virtually every tissue type studied.

Overview

BPC-157 (Body Protection Compound-157) is a pentadecapeptide consisting of 15 amino acids, derived from a protective protein found naturally in human gastric juice. It is arguably the most researched and popular healing peptide in the health optimization community. BPC-157 has demonstrated extraordinary regenerative properties in preclinical studies, accelerating the healing of muscles, tendons, ligaments, bones, and even the nervous system. Its mechanism involves upregulation of growth factor expression (including VEGF, EGF, and FGF), promotion of angiogenesis (new blood vessel formation), modulation of the nitric oxide system, and interaction with the dopaminergic system.

One of BPC-157's most notable properties is its gastroprotective effect — it can heal and protect the gastrointestinal lining, making it valuable for conditions like leaky gut, IBS, and NSAID-induced gastric damage. The peptide also shows neuroprotective properties, with studies demonstrating its ability to counteract the neurotoxic effects of various substances. While the vast majority of research has been conducted in animal models, the consistent and robust results across dozens of studies have made BPC-157 a cornerstone of peptide therapy protocols.

Mechanism of Action

Upregulates growth factors (VEGF, EGF, FGF), promotes angiogenesis, modulates the nitric oxide system (both NOS pathways), interacts with the dopaminergic system, and activates the FAK-paxillin pathway for cell migration and wound healing. Also influences the GABAergic system for neuroprotection.

Key Benefits

Accelerated tendon, ligament, and muscle healing
Gut healing and gastroprotection
Neuroprotective effects
Anti-inflammatory properties
Promotes angiogenesis (new blood vessel formation)
Counteracts NSAID and alcohol-induced damage
Bone fracture healing acceleration
Potential antidepressant effects via dopamine system

Potential Side Effects

Generally very well tolerated
Mild nausea (rare)
Dizziness (rare)
Injection site discomfort

Common Stacks

This compound is commonly combined with the following for synergistic effects:

TB-500GHK-CuKPVIpamorelin

Known Interactions

The following interactions have been documented for BPC-157. Always consult a healthcare professional before combining compounds.

Synergistic (6)

TB-500Synergistic

The most popular healing stack. BPC-157 targets local tissue repair (gut, tendons, ligaments) while TB-500 provides systemic healing through cell migration and angiogenesis.

GHK-CuSynergistic

BPC-157's tissue repair combined with GHK-Cu's collagen stimulation and anti-aging effects creates a comprehensive healing and rejuvenation protocol.

KPVSynergistic

Excellent gut healing stack. BPC-157 repairs gut mucosal lining while KPV reduces gut inflammation through NF-kB inhibition. Found together in the KLOW blend.

Thymosin Alpha-1Synergistic

Thymosin Alpha-1 supports immune function while BPC-157 provides tissue repair. Useful for recovery from illness or injury where both immune and tissue support are needed.

SemaglutideSynergistic

BPC-157 may help protect the GI tract from semaglutide's common GI side effects (nausea, gastroparesis) through its gastroprotective properties.

ARA-290Synergistic

ARA-290 (innate repair receptor agonist) + BPC-157 (tissue repair peptide) provides multi-pathway tissue repair, particularly useful for neuropathy and chronic injuries.

View all compound interactions

BPC-157 Stable vs. Acetate Salt

BPC-157 is commercially available in two distinct salt forms. The form you choose can affect stability, shelf life, and how you administer the peptide.

15

BPC-157 Stable (Arginine Salt)

15 amino acids

Sequence:

Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val (arginine salt)

The arginine salt form of BPC-157 was developed to improve the peptide's stability in solution. It remains active longer after reconstitution and is more resistant to degradation from temperature fluctuations, making it the preferred form for most users.

Superior stability after reconstitution (longer shelf life)
More resistant to temperature and pH changes
Better suited for oral and intranasal administration
Retains potency longer in bacteriostatic water

Best For

Most applications — especially oral dosing, intranasal use, or when the reconstituted peptide will be stored for extended periods.

15

BPC-157 Acetate Salt

15 amino acids

Sequence:

Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val (acetate salt)

The original and more commonly available form of BPC-157. The acetate salt is the standard counter-ion used during peptide synthesis. It is fully effective but less stable in solution compared to the arginine salt form.

More widely available from peptide suppliers
Often lower cost than the stable form
Well-established track record in research
Effective for subcutaneous injection protocols

Best For

Subcutaneous injection protocols where the reconstituted peptide will be used within 2-3 weeks, or when budget is a primary consideration.

View on Zeus Amino Research

Side-by-Side Comparison

AspectBPC-157 Stable (Arginine Salt)BPC-157 Acetate Salt
Stability in SolutionHigh — retains potency for weeksModerate — best used within 2-3 weeks
Oral BioavailabilityBetter suited for oral/intranasal useLess stable in gastric environment
CostSlightly higherGenerally more affordable
AvailabilityGrowing — newer formWidely available from most suppliers

Recommendation: For subcutaneous injection with quick use after reconstitution, the Acetate Salt is perfectly effective and more budget-friendly. For oral or intranasal administration, or if you want maximum shelf life after reconstitution, the Stable (Arginine Salt) form is the better choice.

Which Form Should I Choose?

Answer a few quick questions to get a personalized recommendation based on your research needs.

Scientific References

Quick Reference

Typical Dose

250-500 mcg intranasal, 2-3x/day (men and women).

Frequency

1-2 times daily

Route

Subcutaneous injection (near injury site) or oral

Half-Life

~4 hours (stable in gastric juice)

Cycle Length

4-12 weeks depending on condition

FDA Status

Not FDA approved; research chemical

Need to calculate dosing?

Use our reconstitution calculator to determine exact syringe measurements.

Open Calculator

This information is for educational purposes only. Consult a qualified healthcare professional before using any compound. Dosing information reflects commonly reported protocols and may not be appropriate for everyone.

Related Compounds in Healing & Recovery